Anticytomegalovirus activity of pristimerin, a triterpenoid quinone methide isolated from Maytenus heterophylla (Eckl. & Zeyh.)

Antiviral Chemistry and Chemotherapy

Volumn 18, Issue 3, 2007, Pages 133-139

  Murayama, Tsugiya ^a   Eizuru, Yoshito ^b   Yamada, Rie ^a   Sadanari, Hidetaka ^a   Matsubara, Keiko ^a   Rukung, Geoffrey ^c   Tolo, Festus M ^c   Mungai, Geoffrey M ^d   Kofi Tsekpo, Mawuli ^c  

^a HOKURIKU UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d East African Herbarium   (Kenya)

Author keywords

Antiviral; Cytomegalovirus; Ganciclovir; Maytenus heterophylla; Pristimerin

Indexed keywords

ACETOPHENOL GLYCOSIDE; GANCICLOVIR; LUPEOL; PRISTIMERIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA SYNTHESIS; DRUG EFFECT; DRUG INHIBITION; DRUG ISOLATION; DRUG MECHANISM; EMBRYO; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IC 50; MAYTENUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS REPLICATION;

EID: 34547482030     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020701800303     Document Type: Article

References (41)

1. Ayafor JF, Sondengram BL, Bilon AN & Connolly JD (1986) Limonoids of Teclea ouabanguiensis. Journal of Natural Products 49:583-587.
2. Britt WJ (1996) Cytomegalovirus. In Fields Virology, 3rd edn; pp. 2493-2523. Edited by BN Fields, DM Knipe and PM Howly. Philadelphia: Lippincott-Raven.
3. Buerger I, Reefschlaeger J, Bender W, Eckenberg P, Popp A, Weber O, Graeper S, Klenk HD, Ruebsamen-Waigmann H & Hallenberger S (2001) A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products. Journal of Virology 75:9077-9086.
4. Castillo JP & Kowalik TF (2002) Human cytomegalovirus immediate early protins and cell growth control. Gene 290:19-34.
5. Chang FR, Hayashi K, Chen IH, Liaw CC, Bastow KF, Nakanishi Y, Nozaki H, Cragg GM, Wu YC & Lee KH (2003) Antitumor agents. 228. Five new agarofurans, reissantins A-E, and cytotoxic principles from Reissantia buchananii. Journal of Natural Products 66:1416-1420.
6. Chen CR, Li WG, Wu YJ & Gao MT (2002) The anti-tumor and antioxidation action of pristimerin. Zhongguo Zhong Yao Za Zhi 18:20-21.
7. Dirsch V, Wiemann W & Wagner H (1992) Antiinflammatory activity of triterpene-mediated and proanthocyanidines from the stem bark of Heisteria pallida. England Pharmacology and Pharmacology Letter 2:184-186.
8. Dirsch V, Kiemer A, Wagner H & Vollmer A (1997) The triterpenoid quinonemethide pristimerin inhibits induction of inducible nitric oxide synthase in murine macrophages. European Journal of Pharmacology 336:211-217.
9. El-Tahir A, Satti GMH & Khalid SA (2001) A novel anti-plasmodial activity of pristimerin isolated from Maytenus senegalensis (Lam.). Excellent Journal of Saudi Chemical Society 5:157-163.
10. Figueiredo JN, Raz B & Sequin U (1998) Novel quinine methods from Salacia kraussii with in vitro antimalarial activity. Journal of Natural Products 61:718-723.
11. Freitas VR, Fraser-Smith EB & Matthews TR (1989) Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antiviral Research 12:205-212.
12. Furukawa T, Fioretti A & Plotkin S (1973) Growth characteristics of cytomegalovirus in human fibroblasts with demonstration of protein synthesis early in viral replication. Journal of Virology 11:991-997.
13. Furukawa T, Jisaki F, Sakamuro D, Takegami T & Murayama T (1994) Detection of human cytomegalovirus genome in uterus tissue. Archives of Virology 135:265-277.
14. Gawn JM & Greaves RF (2002) Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. Journal of Virology 76:4441-4455.
15. Gonzalez GJ, Monache DG, Monache DF & Marini-Bottolo BG (1982) Chuchuhuasha - a drug used in folk medicine in the Amazonian and Andean areas. A chemical study of Maytenus laevis. Journal of Ethnopharmacology 5:73-77.
16. Harada K, Eizuru Y, Isashiki Y, Ihara S & Minamishima Y (1997) Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir. Archives of Virology 142:215-225.
17. Hirt B (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. Journal of Molecular Biology 26:365-369.
18. Ho M (1977) Virus infections after transplantation in man. Brief review. Archives of Virology 55:1-24.
19. Ho M (1991) Treatment and prevention of cytomegalovirus infection. In Cytomegalovirus: biology and infection, 2nd edn; pp. 301-317. Edited by M Ho. New York: Plenum publishing corporation.
20. Itokawa H, Shiota O, Ikuta H, Morita H, Takeya K & Itaka Y (1991) Triterpene from Maytenus ilicifolia. Phytochemistry 30:3713-3716.
21. Jacobs JP, Jones CM & Belle JP (1970) Characteristics of a diploid cell designated MRC-5. Nature 227:168-173.
22. Kokwaro JO (1993) Medical plants of East Africa. 2nd edn; p.63. Nairobi: Kenya literature bureau.
23. Lou H, Li X, Zhu T & Li E (1993) Sinapic acid esters and a phenolic glycoside from Cynanchum hancockianum. Phytochemistry 32:1283-1286.
24. Marchini A, Liu H & Zhu H (2001) Human cytomegalovirus with IE-2 (UL122) detected fails to express early lytic genes. Journal of Virology 75:1870-1878.
25. Margolis MJ, Pajovic S, Wong EL, Wada M, Jupp R, Nelson JA & Azizkhan JC (1995) Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. Journal of Virology 69:7759-7767.
26. McSharry JJ, McDonough A, Olson B, Talarico C, Davis M & Biron KK (2001) Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94. Clinical and Diagnostic Laboratory Immunology 8:1279-1281.
27. Meyers JD (1986) Infection in bone marrow transplant recipients. American Journal of Medicine 81:27-38.
28. Murayama T, Kuno K, Jisaki F, Obuchi M, Sakamuro D, Furukawa T, Mukaida N & Matsushima K (1994) Enhancement of human cytomegalovirus replication in a human lung fibroblast cell line by interleukin-8. Journal of Virology 68:7582-7585.
29. Murayama T, Mukaida N, Khabar KSA & Matsushima K (1998) Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection. Journal of Leukocyte Biology 64:62-67.
30. Murayama T, Mukaida N, Sadanari H, Yamaguchi N, Khabar KSA, Tanaka J & Matsushima K (2000) The immediate early gene 1 product of human cytomegalovirus is sufficient for up-regulation of interleukin-8 gene expression. Biochemical and Biophysical Research Communications 279:298-304.
31. Sasaki T, Okayama A, Eizuru Y, Murai K, Matsuoka H, Uno H, Minamishima Y, Kataoka H, Koono M, Matsuura Y, Naoi N, Sawada A, Tachibana N & Tsubouchi H (1997) Progressive retinitis-encephalitis due to ganciclovir-resistant cytomegalovirus associated with aplastic anemia. Internal Medicine 36:375-379.
32. Scholz M, Doerr HW & Cinatl J (2001) Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option? Antiviral Research 49:129-145.
33. Shigeta S, Konno K, Baba M, Yokota T & De Clercq E (1991) Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro. Journal of Infectious Diseases 163:270-275.
34. Shirota O, Morita H, Takeya K & Itokawa H (1994) Cytotoxic aromatic triterpenes from Maytenus ilicifolia and Maytenus chuchuhuasca. Journal of Natural Products 57:1675-1681.
35. Sissons JG & Carmichael AJ (2002) Clinical aspects and management of cytomegalovirus infection. Journal of Infection 44:78-83.
36. Taylor RT & Bresnahan WA (2006) Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression. Journal of Virology 80:920-928.
37. Wentworth BB & French L (1970) Plaque assay of cytomegalovirus strain of human origin. Procedures of Society of Experimental Biology Medicine 135:253-258.
38. Yukawa TA, Kurokawa M, Sato H, Yoshida Y, Kageyama S, Hasegawa T, Namba T, Imakita M, Hozumi T & Shiraki K (1996) Prophylactic treatment of cytomegalovirus infection with traditional herbs. Antiviral Research 32:63-70.
39. Zaia JA (1993) Prevention and treatment of cytomegalovirus pneumonia in transplant recipients. Clinical Infectious Diseases 17:5392-5399.
40. Zhen H, Fang F, Ye D, Shu S, Zhou Y, Dong Y, Nie X & Li G (2006) Experimental study on the action of allitridin against human cytomegalovirus in vitro: inhibitory effects on immediate-early genes. Antiviral Research 72:68-74.
41. Zhu H, Shen Y & Shenk T (1995) Human cytomegalovirus IE1 and IE2 ptoteins block apoptosis. Journal of Virology 69:7960-7970.